Institutional Ownership
Akebia Therapeutics Inc
CUSIP 00972D105COMAKBAQ1 2026
13D / 13G Filings
33
Schedule 13D/13G on record
Beneficial Filers
10
Distinct reporting persons
Largest Stake
16.4%
Max % of class reported
Institutional Holders
166
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
33 filings · latest Feb 9, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 9, 2026 | State Street Corporation | 13G | 5.2% | 13.69M | SEC |
| 2 | Jan 21, 2026 | Blackrock, Inc. | 13G/A | 7.2% | 19.22M | SEC |
| 3 | Apr 30, 2025 | The Vanguard Group | 13G | 5.4% | 12.69M | SEC |
| 4 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 6.1% | 15.14M | SEC |
| 5 | Feb 14, 2025 | Satter Muneer A | 13G/A | 2.6% | 5.75M | SEC |
| 6 | Nov 8, 2024 | Blackrock, Inc. | 13G | 7.2% | 15.20M | SEC |
| 7 | Oct 22, 2024 | Blackrock, Inc. | 13G | 7.2% | 15.20M | SEC |
| 8 | Feb 13, 2024 | Vanguard Group Inc | 13G/A | 4.0% | 7.61M | SEC |
| 9 | Feb 9, 2024 | Satter Muneer A | 13G/A | 8.6% | 16.21M | SEC |
| 10 | Feb 10, 2023 | Satter Muneer A | 13G/A | 8.2% | 15.09M | SEC |
23 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Akebia Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 18.69M | $25.98M |
| 2 | State Street Corp | 11.61M | $16.14M |
| 3 | Geode Capital Management, LLC | 6.45M | $8.97M |
| 4 | Goldman Sachs Group Inc | 3.60M | $5.01M |
| 5 | Citigroup Inc | 2.85M | $3.97M |
| 6 | Bank Of America Corp /De/ | 2.76M | $3.84M |
| 7 | Qube Research & Technologies Ltd | 2.40M | $3.33M |
| 8 | Millennium Management LLC | 2.38M | $3.31M |
| 9 | Charles Schwab Investment Management Inc | 2.02M | $2.80M |
| 10 | Nantahala Capital Management, LLC | 2.00M | $2.78M |